Novartis (Intellectual Property Rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Novartis (Intellectual Property Rights) General Information
Description
Portfolio of trademark and intellectual property rights of the antidepressant drug Pamelor. Pamelor is an antidepressant drug whose active ingredient is Nortriptyline Hydrochloride and is approved by the Food and Drug Administration (FDA) of the United States.
Contact Information
Corporate Office
- Brazil
Corporate Office
- Brazil
Novartis (Intellectual Property Rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novartis (Intellectual Property Rights) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novartis (Intellectual Property Rights) FAQs
-
Where is Novartis (Intellectual Property Rights) headquartered?
Novartis (Intellectual Property Rights) is headquartered in Brazil.
-
What industry is Novartis (Intellectual Property Rights) in?
Novartis (Intellectual Property Rights)’s primary industry is Buildings and Property.
-
Is Novartis (Intellectual Property Rights) a private or public company?
Novartis (Intellectual Property Rights) is a Private company.
-
What is Novartis (Intellectual Property Rights)’s current revenue?
The current revenue for Novartis (Intellectual Property Rights) is .
-
Who are Novartis (Intellectual Property Rights)’s investors?
Novartis has invested in Novartis (Intellectual Property Rights).
-
When was Novartis (Intellectual Property Rights) acquired?
Novartis (Intellectual Property Rights) was acquired on 22-Dec-2017.
-
Who acquired Novartis (Intellectual Property Rights)?
Novartis (Intellectual Property Rights) was acquired by Cellera Farmacêutica.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process